Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39052

DNAH5 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

CRISPR/Cas9 polyclonal knockout of DNAH5 in SK-HEP-1 cells provides a human-based model for studying outer dynein arm dysfunction. DNAH5 encodes a dynein heavy chain essential for motile cilia beat generation, regulated by factors such as FOXJ1 and RFX2, and its disruption impairs ciliary motility and mucociliary clearance. This knockout cell pool enables investigation of ciliogenesis, left?Cright asymmetry, and ciliopathy mechanisms, with applications including ciliary beat analysis, protein localization, and compound screening for primary ciliary dyskinesia. Contact Ascent Research for additional information.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    DNAH5

    Gene Identifier

    NCBI Gene ID 1767

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAH5 Knockout SK-HEP-1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal population derived from the SK-HEP-1 human hepatic sinusoidal endothelial cell line, carrying a targeted disruption of the DNAH5 gene. DNAH5 encodes an axonemal dynein heavy chain essential for the assembly of outer dynein arms in motile cilia, and its loss of function serves as a genetically defined model for primary ciliary dyskinesia and related ciliopathies. This product provides a mixed knockout pool rather than a monoclonal line, enabling the study of gene disruption effects across a spectrum of allelic variants without fixation on a single clone.

The host cell model, SK-HEP-1, is an established adherent line originally derived from a human hepatic adenocarcinoma and extensively characterized as a surrogate for liver sinusoidal endothelial cells. These cells natively fulfill roles in blood filtration, metabolic exchange, and sinusoidal lining, and they have been adapted for diverse biomedical research applications. Although SK-HEP-1 cells are not classical ciliated epithelia, they can express components of the ciliary machinery under appropriate conditions, making them a tractable system for investigating motile cilia gene function in a readily manipulable human cell background.

At the molecular level, DNAH5 functions as a core component of the outer dynein arm, generating ATP-dependent force for ciliary beat. Its transcription is regulated by key ciliogenesis factors including FOXJ1, RFX2, RFX3, and MCIDAS, while the assembled protein complex interacts with other outer dynein arm constituents such as DNAH11, DNAI1, DNAI2, and DNALI1. Disruption of DNAH5 abolishes outer dynein arm formation, leading to impaired ciliary motion, reduced beat frequency, and downstream failures in mucociliary clearance, fluid flow generation, and establishment of left?Cright body asymmetry??hallmarks of Kartagener syndrome and primary ciliary dyskinesia.

In the context of SK-HEP-1 knockout cells, DNAH5 ablation creates a loss-of-function model that allows researchers to dissect the structural and functional consequences of outer dynein arm deficiency without the complexity of primary ciliated cell culture. This cellular background facilitates biochemical analyses of dynein complex assembly and stability, as well as live-cell imaging of residual ciliary dynamics. The knockout pool can be used to screen for pharmacological rescue agents or to introduce wild-type and mutant DNAH5 constructs for structure?Cfunction studies, providing a flexible platform complementary to animal models and patient-derived samples.

Typical applications include high-speed video microscopy to measure ciliary beat frequency, immunofluorescence staining for localization of ciliary markers (e.g., acetylated ??-tubulin, DNAI1), western blotting for outer dynein arm protein levels, RT-qPCR profiling of ciliogenesis transcription factors, and mucociliary clearance assays. This product is particularly suited for functional genomics screening, ciliopathy drug discovery, and investigation of cilia-dependent signaling pathways. For detailed inquiries or to discuss custom applications, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)